Stay updated on Nivolumab Ipilimumab Local Consolidation Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Local Consolidation Clinical Trial page
- Check4 days agoChange DetectedA new revision label (v3.5.4) appears, replacing the previous label (v3.5.3), indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s displayed revision/version changed from v3.5.2 to v3.5.3, indicating an update to the page release rather than study content.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedPrimary completion and study completion dates updated to 2027-03-31; the previous 2026-03-31 date has been removed. New March 2026 entries (2026-03-23 and 2026-03-20) were added to the study record.SummaryDifference0.3%

- Check62 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated to v3.4.3; the previous version v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Ipilimumab Local Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.